pharma
publication date
Strategy
States Move Ahead With Canada Drug Importation While Awaiting Signal From BidenThe Pharmaceutical Research and Manufacturers of America, an industry trade group, filed suit in federal court in Washington, D.C., to...
Clinical Care
Fewer Physicians Accepting Industry Payments, But Payment Values Stay SteadyA new study highlights the importance of tracking physician conflicts of interest.
Strategy
Drug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug PricesPhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
Finance
Pharmacists Call on N.Y. to Lift Restrictions to Fight CoronavirusThe Pharmacists Society of the State of New York released a six-point plan to address the outbreak.
Finance
Revenues Jumped 32% for CVS, Operating Income up to $12BThe company made a series of leadership changes in addition to releasing its earnings report.
Finance
Allergan Shareholders Approve $63B Abbvie AcquisitionThe deal, first announced in June, received near-unanimous approval from the Dublin-based pharmaceutical company's shareholders.
Finance
California's New Transparency Law Reveals Steep Rise In Wholesale Drug PricesGeneric drugs saw the largest median increase of 37.6% from 2017 through the first quarter of 2019.
Finance
PhRMA: Pelosi Bill Would Mean 'Lights Out' for Drug StartupsDrug lobby, feeling heat from Capitol Hill, ramps up its rhetoric.
Finance
Large Chain Pharmacies Have Lowest Cash Prices for Generics, Less VariationConsumers might be better off price shopping for generic prescription drugs, according to a new study.
Finance
Medicaid Pharmacy Cost Trend Increases Despite Drop in UtilizationOne of the most notable data points was the nearly flat rate for average claim cost, increasing 0.8%, compared to...
Finance
Pharma Cash Rolls Into Congress To Defend An Embattled IndustryThe big contributions that lawmakers are getting signal that the pharmaceutical industry is building loyalty ahead of the 2020 elections.
Finance
Celgene Sells Otezla to Amgen for $13.4B, Bristol-Myers Squibb AnnouncesThe announcement is the latest development as New York-based Bristol-Myers Squibb looks to close on its purchase of Celgene.